OUP (OSAGE UNIVERSITY PARTNERS)
Osage University Partners is a venture capital firm focused on investing in startups that are commercializing university technologies. Osage partners with research universities to invest in their innovative startups shareing its investment profit with partner institutions. The firm invests in software, hardware, and life science companies at all stages of company development. To date, it has partnered with over 80 universities, including 36 of the top 50 U.S. institutions by research expenditures, and has invested in over 50 of their spinouts.
OUP (OSAGE UNIVERSITY PARTNERS)
Industry:
Biotechnology Finance Financial Services Medical Device Pharmaceutical Venture Capital
Founded:
2009-01-01
Status:
Active
Contact:
+1 (484) 434-2255
Email Addresses:
[email protected]
Technology used in webpage:
Google Google Cloud Google Cloud Iowa PowWeb DNS
Similar Organizations
Flybridge
Flybridge is a seed-stage venture capital firm investing with entrepreneurs to leverage the power of the community.
HealthCare Royalty Partners
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.
UpWest
UpWest is a Silicon Valley-based seed fund investing in Israel’s most promising entrepreneurs targeting the US market.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-18 | Delfi Diagnostics | OUP (Osage University Partners) investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-06-27 | Nikola Labs | OUP (Osage University Partners) investment in Series A - Nikola Labs | 9 M USD |
| 2022-06-20 | MicroTransponder | OUP (Osage University Partners) investment in Series E - MicroTransponder | 53 M USD |
| 2022-03-24 | Brimstone Energy | OUP (Osage University Partners) investment in Series A - Brimstone Energy | 55 M USD |
| 2021-11-02 | Antiva Biosciences | OUP (Osage University Partners) investment in Series D - Antiva Biosciences | 31 M USD |
| 2021-10-21 | ReCode Therapeutics | OUP (Osage University Partners) investment in Series B - ReCode Therapeutics | 80 M USD |
| 2021-09-14 | Vanqua Bio | OUP (Osage University Partners) investment in Series B - Vanqua Bio | 85 M USD |
| 2021-09-02 | Corelight | OUP (Osage University Partners) investment in Series D - Corelight | 75 M USD |
| 2021-08-26 | Effector Therapeutics | OUP (Osage University Partners) investment in Post-IPO Equity - Effector Therapeutics | 60 M USD |
| 2021-08-24 | Dice Therapeutics | OUP (Osage University Partners) investment in Series C - Dice Therapeutics | 60 M USD |